Know Cancer

or
forgot password

UARK 91-004 Therapeutic Research in Multiple Myeloma


N/A
18 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma

Thank you

Trial Information

UARK 91-004 Therapeutic Research in Multiple Myeloma


Participating in this study will require that blood and bone marrow samples be obtained as a
part of the diagnostic work-up or follow-up of your multiple myeloma. Bone marrow/peripheral
blood/tissue samples will be collected for research purposes, as well as testing for genetic
traits of Castleman's disease if you consent to this study. In addition, data will be
collected including demographic information gathered from your medical record, including
gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology results,
treatment protocols, dates of relapses, subsequent treatment protocols, and current
treatments and medications.


Inclusion Criteria:



- Any subject evaluated for a MIRT protocol

Exclusion Criteria:

- Subjects who have not been evaluated for a MIRT protocol

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Principal Investigator

Bart Barlogie, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

UAMS Myeloma Institute for Research and Therapy

Authority:

United States: Institutional Review Board

Study ID:

UARK 91-004

NCT ID:

NCT00572338

Start Date:

August 2003

Completion Date:

December 2015

Related Keywords:

  • Multiple Myeloma
  • Multiple Myeloma
  • Neoplasms, Plasma Cell

Name

Location

University of Arkansas for Medical Sciences/MIRTLittle Rock, Arkansas  72205